Regulation of Aberrant Protein Production
Regulation of Aberrant Protein Production
批准号:
10248453
负责人:
Andrey L Karamyshev
金额:
$30.6万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-16 至 2023-08-31
关键词:
AddressCellsComplexDefectDetectionDiseaseEnzymesGenetic TranscriptionHormonesHumanImmunofluorescence ImmunologicIn VitroKnowledgeLeadMammalian CellMass Spectrum AnalysisMediatingMembrane ProteinsMessenger RNAModelingMolecularMonitorMutationNorthern BlottingPathway interactionsPeptide Signal SequencesProcessProductionProlactinProteinsQuality ControlRegulationResearchRibosomesSignal Recognition ParticleSiteStressSystemTechnologyTestingTranslational RepressionTranslationsUbiquitinWestern Blottingcrosslinkdesignendonucleasehuman diseasein vivoknock-downmRNA Transcript Degradationmisfolded proteinmulticatalytic endopeptidase complexnoveloverexpressionpolypeptidepolysome profilingpreventprotein aggregationprotein expressionresponsesecretory proteinsensortranscriptometranscriptome sequencing
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
Defective proteins result from mutations, mistakes of transcription, stress, and other factors. These aberrant
proteins are often toxic and cause a number of human diseases. There are several quality control (QC)
pathways in the cells: nonsense-mediated, no-stop, and no-go decays for defective mRNAs, and the
ubiquitin/proteasome system for already synthesized misfolded proteins. Recently, we discovered a new QC
pathway called Regulation of Aberrant Protein Production (RAPP). RAPP is a preemptive QC, it monitors
proteins during their synthesis at the ribosome, senses defective proteins and degrades their mRNA templates.
It is the first example of transferring information about aberrant proteins to mRNA degradation machinery.
Normally, nascent polypeptides emerged from the ribosome exit tunnel interact with targeting or folding factors.
When a mutation prevents these interactions, the Ago2 protein, a sensor in the RAPP response, detects the
loss of these important interactions and triggers mRNA degradation. Surprisingly, Ago2 endonuclease activity
is not required in the process. Thus, the molecular mechanism of RAPP is not well understood, very little is
known about its mRNA degradation machinery and its substrates. The proposed project will fill these gaps in
knowledge. Our hypothesis is that RAPP is a general protein quality control pathway that consists of three
major steps: detection of an aberrant nascent chain complex, translational repression, and formation of
specialized cytoplasmic foci for degradation of the aberrant mRNA. Our specific aims are designed to test this
hypothesis and directed to (1) elucidate the mechanism by which protein expression is down-regulated in
RAPP, and (2) determine whether RAPP is a general mechanism of protein quality control for secretory and
membrane proteins in mammalian cells. The proposal involves application of comprehensive in vivo and in
vitro approaches, including our unique technology, iPINCH, for identification of Proteins Interacting with
Nascent Chains. Determining the scope and mechanism of RAPP will impact the field of protein quality control
research by providing a better understanding of cellular defense against erroneous and potentially toxic
proteins.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of an Anti-Cancer Approach Through a Novel Pathway of Translational Regulation
-
批准号:10727837
-
项目类别:
-
资助金额:$15.3万
-
财政年份:2023
-
负责人:Andrey L Karamyshev
-
依托单位:
Regulation of Aberrant Protein Production
-
批准号:10475220
-
项目类别:
-
资助金额:$30.6万
-
财政年份:2019
-
负责人:Andrey L Karamyshev
-
依托单位:
Regulation of Aberrant Protein Production
-
批准号:10019580
-
项目类别:
-
资助金额:$30.6万
-
财政年份:2019
-
负责人:Andrey L Karamyshev
-
依托单位:
国内基金
海外基金
登录
查看更多内容
分化肌细胞脱细胞ECM-cells sheet 3D
支架构建及其促进容积性肌组织缺损再
生修复应用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:肖将尉
-
依托单位:
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
-
批准号:82072862
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2020
-
负责人:徐云升
-
依托单位:
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
-
批准号:82070825
-
项目类别:面上项目
-
资助金额:53.0万元
-
批准年份:2020
-
负责人:徐西振
-
依托单位:
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
-
批准号:81903002
-
项目类别:青年科学基金项目
-
资助金额:20.5万元
-
批准年份:2019
-
负责人:王斐斐
-
依托单位:
HA/CD44在乳腺癌转移“先导细胞”(leader cells)侵袭中的作用及机制研究
-
批准号:81402419
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2014
-
负责人:杨翠霞
-
依托单位:
双模式编码的慢病毒载体转染C6 Glioma Cells的影像学研究
-
批准号:81271563
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2012
-
负责人:陈正光
-
依托单位:
树突状细胞(Dendritic cells,DCs)介导的黏膜免疫对猪轮状病毒(PRV)感染的分子作用机制研究
-
批准号:31272541
-
项目类别:面上项目
-
资助金额:82.0万元
-
批准年份:2012
-
负责人:王春凤
-
依托单位:
MTA2在睾丸支持细胞(Sertoli cells)中的功能和机制研究
-
批准号:31271248
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2012
-
负责人:李伟
-
依托单位:
无外源性基因iPS cells向肠细胞分化及对肠损伤的修复
-
批准号:81160050
-
项目类别:地区科学基金项目
-
资助金额:49.0万元
-
批准年份:2011
-
负责人:邵立健
-
依托单位: